http://www.nhs.uk/news/2017/01January/Pages/New-drug-treatment-for-pancreatic-cancer-extends-survival.aspx
Citando:
"The trial showed people lived an average of 2.5 months longer if they took two drugs than if they took just one. Pancreatic cancer has a poor outlook compared with many other cancers.
Using information from the study, researchers estimated that the chances of people living for five years were 28.8% for those who took both drugs, compared with 16.3% for those treated with one drug.
However, not everyone involved in the trial was followed up for five years, so we don't know how reliable these longer-term estimates are.
The researchers say the two-drug combination should be "the new standard of care" for people who've had surgery for pancreatic cancer.
But people who took both drugs were more likely to stop treatment early because of the toxic side effects of chemotherapy.
This is an important consideration for people whose treatment can only prolong life and not achieve a cure, as there is always going to be a trade-off between survival time and quality of life."
